Sanofi | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 16.59B 5.96B 2024-12
Amgen USD 6.78B 401M 2024-12
AstraZeneca USD 12.86B 2.06B 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Galapagos EUR 138.22M 24.07M 2024-12
Genmab DKK 4.25B 812M 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Glaxosmithkline GBP 7.42B 408M 2024-12
Indivior 213M 218M 2024-09
J&J USD 18.63B 500M 2024-12
Merck USD 11.33B 1.4B 2024-12
Novartis USD 11.28B 1.73B 2024-12
Novartis USD 10.15B 579M 2024-12
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Prestige Brands USD 198.36M 1.09M 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 10.07B 969M 2024-09
Sanofi EUR 10.52B 1.42B 2024-09
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
UCB EUR 1.23B 1.31B 2024-06
Zoetis USD 1.59B 71M 2024-12



Sanofi Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.